Gray Matter Pathology in MS: A 3-Year Longitudinal Study in a Pediatric Population

References

1. 1.↵
   1. Noseworthy JH,
   2. Lucchinetti C,
   3. Rodriguez M,
   4. et al

   . Multiple sclerosis. N Engl J Med 2000; 343: 938– 52

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Chard DT,
   2. Miller D.

   . Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009; 282: 5– 11

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Vercellino M,
   2. Masera S,
   3. Lorenzatti M,
   4. et al

   . Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68: 489– 502

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Simon JH,
   2. Kinkel RP,
   3. Jacobs L,
   4. et al

   . A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000; 54: 1155– 60

   Abstract/FREE Full Text
5. 5.↵
   1. Trapp BD,
   2. Peterson J,
   3. Ransohoff RM,
   4. et al

   . Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278– 85

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Pirko I,
   2. Lucchinetti CF,
   3. Sriram S,
   4. et al

   . Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634– 42

   Abstract/FREE Full Text
7. 7.↵
   1. Chard DT,
   2. Griffin CM,
   3. Rashid W,
   4. et al

   . Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004; 10: 387– 91

   Abstract/FREE Full Text
8. 8.↵
   1. Dalton CM,
   2. Chard DT,
   3. Davies GR,
   4. et al

   . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101– 07

   Abstract/FREE Full Text
9. 9.↵
   1. De Stefano N,
   2. Matthews PM,
   3. Filippi M,
   4. et al

   . Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003; 60: 1157– 62

   Abstract/FREE Full Text
10. 10.↵
    1. Calabrese M,
    2. Atzori M,
    3. Bernardi V,
    4. et al

    . Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212– 20

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Pohl D,
    2. Hennemuth I,
    3. von Kries R,
    4. et al

    . Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr 2007; 166: 405– 12

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Banwell B,
    2. Krupp L,
    3. Kennedy J,
    4. et al

    . Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007; 6: 773– 81

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Atzori M,
    2. Battistella PA,
    3. Perini P,
    4. et al

    . Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler 2009; 3: 363– 70
14. 14.↵
    1. Barkhof F,
    2. Filippi M,
    3. Miller DH,
    4. et al

    . Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059– 69

    Abstract/FREE Full Text
15. 15.↵
    1. Polman CH,
    2. Reingold SC,
    3. Edan G,
    4. et al

    . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005; 58: 840– 46

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444– 52

    Abstract/FREE Full Text
17. 17.↵
    1. Giorgio A,
    2. Santelli L,
    3. Tomassini V

    . Age-related changes in grey and white matter structure throughout adulthood. Neuroimage 2010; 51: 943– 51

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Geurts JJ,
    2. Roosendaal SD,
    3. Calabrese M,
    4. et al

    . Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011; 76: 418– 24

    Abstract/FREE Full Text
19. 19.↵
    1. Calabrese M,
    2. De Stefano N,
    3. Atzori M,
    4. et al

    . Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64: 1416– 22

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Miller DH,
    2. Barkhof F,
    3. Frank JA,
    4. et al

    . Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676– 95

    Abstract/FREE Full Text
21. 21.↵
    1. Calabrese M,
    2. Gallo P

    . Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009; 15: 933– 41

    Abstract/FREE Full Text
22. 22.↵
    1. Calabrese M,
    2. Rocca MA,
    3. Atzori M,
    4. et al

    . Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 2009; 72: 1330– 36

    Abstract/FREE Full Text
23. 23.↵
    1. Calabrese M,
    2. Battaglini M,
    3. Giorgio A,
    4. et al

    . Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology 2010; 75: 1234– 40

    Abstract/FREE Full Text
24. 24.↵
    1. Kidd D,
    2. Barkhof F,
    3. McConnell R,
    4. et al

    . Cortical lesions in multiple sclerosis. Brain 1999; 122: 17– 26

    Abstract/FREE Full Text
25. 25.↵
    1. Fisniku LK,
    2. Chard DT,
    3. Jackson JS,
    4. et al

    . Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247– 54

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Calabrese M,
    2. Rocca MA,
    3. Atzori M,
    4. et al

    . A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010; 67: 376– 83

    PubMedWeb of Science
27. 27.↵
    1. Kutzelnigg A,
    2. Lucchinetti CF,
    3. Stadelmann C,
    4. et al

    . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705– 12

    Abstract/FREE Full Text
28. 28.↵
    1. Bö L,
    2. Geurts JJ,
    3. VanderValk P,
    4. et al

    . Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007; 64: 76– 80

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Charil A,
    2. Filippi M

    . Inflammatory demyelination and neurodegeneration in early multiple sclerosis. J Neurol Sci 2007; 259: 7– 15

    CrossRefPubMedWeb of Science